MENLO PARK, Calif.--(BUSINESS WIRE)--According to Scientific American, electroceuticals, a branch of neurotechnology, is one of the top 10 emerging technologies of 2018. One of the prominent neurotechnology organizations, Neurotech Reports, held their annual Neurotech Leaders Forum recently in San Francisco, California. During the event, Tivic Health Systems was awarded the Gold Electrode Award for Most Promising Start-up. Blake Gurfein, PhD, Tivic Health’s VP of Research and Scientific Affairs and Assistant Professor at UC San Francisco, presented a talk and accepted the award.
James Cavuoto, editor and publisher of The Neurotech Business Report says, “Our editors were impressed by Tivic Health’s innovative technology to address an unmet medical need. The scientific and management team seem well positioned to bring the ClearUP Sinus Pain Relief device to market.” Gurfein adds, “I was attracted to join Tivic Health because they are lean, execution-oriented and serious about evidence-based products that are efficacious and address real clinical needs. Because of my previous research in neuromodulation, I saw the potential promise of the ClearUP Sinus Pain Relief device. In less than a year, we have progressed from a well-designed prototype to FDA clearance-pending.”
The Neurotech Leaders Forum is a two-day conference for neurotechnology executives and entrepreneurs to interact with investors, partners and technologists. This year it attracted 120 international and US neurotechnology professionals.
Tivic Health is actively engaging with investor communities in preparation for the ClearUP™ Sinus Pain Relief launch.
FDA 510 K clearance is pending. ClearUP™ Sinus Pain Relief is an investigational technology. Claims have not been evaluated by the FDA. This device is not currently for sale in the U.S.
About Tivic Health Systems Inc.
Tivic Health Systems Inc. (Tivic Health™) is a bioelectronic device company dedicated to developing microcurrent therapy solutions for chronic diseases and conditions. Tivic Health’s first product, ClearUP™ Sinus Pain Relief, targets sinus pain associated with chronic sinusitis, allergic rhinitis and other common sources of sinus pain.
Tivic Health, founded in 2016, is part of a $6.2B global neuromodulation industry. The team is dedicated to harnessing the power of neuromodulation for home use products, empowering people to improve their health and quality of life.
Forward Looking Statement
This news release contains forward-looking statements that are based on the current expectations and beliefs of Tivic Health Systems Inc. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including FDA clearance, product launch and timing.